You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study

Citation Tools

Article menu

This article has a correction. Please see:

Clinical trials and drug discovery
Original research
First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hermann V, Batalov A, Smakotina S, et al
First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study
Lupus Science & Medicine 2019;6:e000354. doi: 10.1136/lupus-2019-000354